Author Search Results :: UTM Library Massive Scholar Tracking

1

Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma by Estefanía García-Guerrero, Belén Sierro-Martínez, Jose Antonio Pérez-Simón

Published 2020-06-01

Get full text

Article

2

Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resi... by Maria-Luisa del Rio, Maria-Luisa del Rio, Jose-Antonio Perez-Simon, Jose-Antonio Perez-Simon, Jose-Ignacio Rodriguez-Barbosa, Jose-Ignacio Rodriguez-Barbosa

Published 2022-06-01

Get full text

Article

3

Current Status of CAR-T Cell Therapy in Multiple Myeloma by Juan Luis Reguera-Ortega, Estefanía García-Guerrero, Jose Antonio Pérez-Simón

Published 2021-10-01

Get full text

Article

4

The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens by Jose-Ignacio Rodriguez-Barbosa, Pascal Schneider, Luis Graca, Leo Bühler, Jose-Antonio Perez-Simon, Maria-Luisa del Rio

Published 2020-05-01

Get full text

Article

5

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations by Beatriz Guijarro-Albaladejo, Cristina Marrero-Cepeda, Eduardo Rodríguez-Arbolí, Belén Sierro-Martínez, José Antonio Pérez-Simón, Estefanía García-Guerrero

Published 2024-04-01

Get full text

Article

6

The Dynamics of the Human Leukocyte Antigen Head Domain Modulates Its Recognition by the T-Cell Receptor. by Estefanía García-Guerrero, José Antonio Pérez-Simón, Luis Ignacio Sánchez-Abarca, Irene Díaz-Moreno, Miguel A De la Rosa, Antonio Díaz-Quintana

Published 2016-01-01

Get full text

Article

7

Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression by Maria-Luisa del Rio, Carla Yago-Diez de Juan, Giovanna Roncador, Eduardo Caleiras, Ramón Álvarez-Esteban, José Antonio Pérez-Simón, Jose-Ignacio Rodriguez-Barbosa

Published 2023-03-01

Get full text

Article

8

$Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis$

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis by Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón

Published 2017-12-01

Get full text

Article

9

$First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia$

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia by Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D. Goldberg, Michael R. Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez‐Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso‐Dominguez

Published 2023-03-01

Get full text

Article

10

Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice by Luis Ignacio Sánchez-Abarca, Emiliano Hernández-Galilea M.D., Rebeca Lorenzo, Carmen Herrero, Almudena Velasco, Soraya Carrancio, Teresa Caballero-Velázquez, José Ignacio Rodríguez-Barbosa, Marta Parrilla, Consuelo Del Cañizo, Jesús San Miguel, José Aijón, José Antonio Pérez-Simón M.D., Ph.D.

Published 2015-12-01

Get full text

Article

11

Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases by Ana Belén Guisado-Gil, Manuela Aguilar-Guisado, Germán Peñalva, José Antonio Lepe, Ildefonso Espigado, Eduardo Rodríguez-Arbolí, José González-Campos, Nancy Rodríguez-Torres, María Isabel Montero-Cuadrado, José Francisco Falantes-González, Juan Luis Reguera-Ortega, María Victoria Gil-Navarro, José Molina, José-Antonio Pérez-Simón, José Miguel Cisneros

Published 2021-01-01

Get full text

Article

12

$Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring$

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric an... by Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Melissa Panesso, Montserrat Torrebadell, Javier Delgado-Serrano, Concepción Pérez de Soto, Anna Faura, Berta González-Martínez, Ana Castillo-Robleda, Cristina Diaz-de-Heredia, Antonio Pérez-Martínez, José María Pérez-Hurtado, Susana Rives, Susana Rives, José Antonio Pérez-Simón

Published 2024-02-01

Get full text

Article

13

$Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring$